PMC-002

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePMC-002

Drug Alias NamePMC-002

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsHepatocyte growth factor receptor inhibitors

TargetsVascular endothelial growth factor receptor 2Hepatocyte growth factor receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPharmAbcine Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPharmAbcine Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A